4 analysts have shared their evaluations of Option Care Health (NASDAQ:OPCH) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 3 | 1 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 2 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $36.0, along with a high estimate of $38.00 and a low estimate of $30.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 3.56%.
The standing of Option Care Health among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Charles Rhyee | TD Cowen | Announces | Hold | $30.00 | - |
Michael Petusky | Barrington Research | Maintains | Outperform | $38.00 | $38.00 |
Constantine Davides | JMP Securities | Raises | Market Outperform | $38.00 | $36.00 |
Michael Petusky | Barrington Research | Maintains | Outperform | $38.00 | $38.00 |
Capture valuable insights into Option Care Health's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Option Care Health analyst ratings.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Option Care Health's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 15.39% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Option Care Health's net margin is impressive, surpassing industry averages. With a net margin of 3.57%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Option Care Health's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.73%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.51%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 0.9, Option Care Health faces challenges in effectively managing its debt levels, indicating potential financial strain.
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.